Mankind Pharma BSV Acquisition: Game-Changing ₹9,000 Crore Investment Set to Elevate Biotech Sector
Explore the strategic Mankind Pharma BSV acquisition valued at ₹9,000 crore, a move set to revolutionize the biotech industry and elevate Mankind Pharma’s global presence.